跳至主要内容
临床试验/JPRN-UMIN000016837
JPRN-UMIN000016837已完成未知

Evaluation of Prognostic Impact of Serum Autoantibody in Patients with Metastatic Non-small-Cell Lung Cancer without EGFR activating mutation nor ALK fusion gene - Prognostic Impact of Serum Autoantibody in Metastatic Non-small-Cell Lung Cancer without activating mutations

Dept. of Thoracic Oncology, Kansai Medical University Hospital0 个研究点目标入组 72 人开始时间: 2015年3月20日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
72

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Concomitant other malignancy 2. Life expectancy <= 3 months 3. Use of steroid hormone, immunosuppressant, or biologic drug within 4 weeks at the time of enrollment 4. Severe active infection or poorly controlled disease ( e.g. hypertension, diabetes mellitus, cardiac disorder, gastro-intestinal bleeding, and so on) 5. Pregnant, possibly pregnant or lactating woman 6. Requiring radiation therapy to brain, mediastinum, or lung 7. Concomitant obvious interstitial lung disease on chest computed tomography 8. Poorly controlled malignant effusion requiring drainage 9. Otherwise determined by the investigator or the attending physician to be unsuitable as a subject in this study

研究者

发起方
Dept. of Thoracic Oncology, Kansai Medical University Hospital

相似试验